FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $637,000 | +422.1% | 10,885 | +427.1% | 0.14% | +264.9% |
| Q3 2021 | $122,000 | -85.6% | 2,065 | -78.9% | 0.04% | -84.8% |
| Q2 2021 | $850,000 | +51.8% | 9,792 | +44.2% | 0.24% | +28.4% |
| Q1 2021 | $560,000 | -16.3% | 6,792 | -7.6% | 0.19% | -12.0% |
| Q4 2020 | $669,000 | -46.6% | 7,352 | -76.5% | 0.22% | -43.2% |
| Q3 2020 | $1,252,000 | +51.4% | 31,317 | +30.0% | 0.38% | +61.7% |
| Q2 2020 | $827,000 | – | 24,092 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |